Jeil Pharmaceutical Co., Ltd.: all 56 studies

Page 1 of 1. Open to participants first (12), then studies with results posted, then the rest; newest registration first within each.

• Post-Marketing Surveillance to Evaluate the Safety and Effectiveness of Zastaprazan CitrateRecruitingNCT07894939
• Efficacy and Safety of JP-1366-based Triple Therapy in Helicobacter Pylori-positive SubjectsNot yet recruitingNCT07875933Phase 3
• Phase 3 Study of JP-1366: Efficacy and Safety of JP-1366 as Maintenance Therapy in Subjects With Healed Erosive EsophagitisNot yet recruitingNCT07732075Phase 3
• Food and Ethnicity Effects on Pharmacokinetics and Safety of JPI-547 in Healthy Male ParticipantsNot yet recruitingNCT07570186Phase 1
• To Evaluate the Efficacy and Safety of JPI-547 in Combination With Bevacizumab as Maintenance Therapy in Relapsed Ovarian CancerNot yet recruitingNCT07370818Phase 2
• To Evaluate the Safety and Tolerability of Study Drug as a Third-line and Beyond Therapy for Recurrent or Metastatic Gastric CancerNot yet recruitingNCT07364422Phase 1/2
• to Evaluate the Safety and the Pharmacokinetic and Pharmacodynamic Interactions Between JP-1366 and Clopidogrel, Aspirin, Atorvastatin and ApixabanRecruitingNCT07265466Phase 1
• Phase 3 Study of JP-1366: Efficacy and Safety of JP-1366 in Patients With Non-erosive Gastroesophageal Reflux DiseaseNot yet recruitingNCT07160790Phase 3
• JAQBO® Tab. 20 mg(Zastaprazan Citrate) in Erosive GERDNot yet recruitingNCT07115706
• Study to Evaluate the Efficacy and Safety of JP-1366 in the Prevention of NSAIDs-Induced Peptic UlcersRecruitingNCT06439563Phase 3
• To Evaluate the Safety, Pharmacokinetic Characteristics and the Effect of Food After Administration of JLP-2004RecruitingNCT06431399Phase 1
• Study to Assess the Safety, Tolerability of JPI-547 in Combination With Modified FOLFIRINOX or Gemcitabine-nab-paclitaxel in Patients With Locally Advanced and Metastatic Pancreatic CancerRecruitingNCT05257993Phase 1/2
• Phase 1 Study of JLP-2302 and JP-1366: PK and Safety in Healthy VolunteersCompletedNCT07181538Phase 1
• Observationa Study is a Prospective and Multi-institutional Observational Study.CompletedNCT06952855
• To Evaluate the Safety and Pharmacokinetic Characteristics After the Administration of JC-001 and JLP-1901CompletedNCT06171880Phase 1
• To Evaluate the Safety and Pharmacokinetic Characteristics After Multiple Administration of JC-013 and JLP-2004CompletedNCT06169059Phase 1
• To Evaluate the Safety and Pharmacokinetic Characteristics After the Administration of JT-001, JT-002 and JLP-2008CompletedNCT06165965Phase 1
• Evaluation of Efficacy and Safety When Administered JP-2266 in Type 2 Diabetes PatientsCompletedNCT06144788Phase 2
• Clinical Trial to Evaluate the Safety and Pharmacokinetics of JP-1366 in Healthy Adult VolunteersCompletedNCT05814809Phase 1
• Clinical Trial to Evaluate Food-Effects on Pharmacokinetics and Pharmacodynamics of Oral Single Dose of JP-1366 Tablet in Healthy VolunteersCompletedNCT05712681Phase 1
• A Study to Evaluate the Efficacy and Safety of JPI-547 in Platinum-resistant, Advanced/Relapsed Ovarian Cancer Subjects Previously Treated With a PARP InhibitorActive, not recruitingNCT05475184Phase 2
• Clinical Trial to Evaluate the Efficacy and Safety of JP-1366 in Patients With Gastric UlcerCompletedNCT05448001Phase 3
• JP-1366 20mg Versus Esomeprazole 40mg in Patients With Erosive EsophagitisCompletedNCT05443984Phase 3
• To Evaluate the Efficacy and Safety of JT-003 add-on in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin and DapagliflozinStatus unknownNCT05296044Phase 3
• Drug-drug Interactions and Safety Among JP-1366, Amoxicillin, and Clarithromycin in Healthy VolunteersCompletedNCT05194046Phase 1
• Compare Pharmacokinetics and Safety of JP-1366 Between Korean and CaucasianCompletedNCT05181124Phase 1
• Safety, Tolerability, and Pharmacokinetic and Pharmacodynamic Characteristics of JP-2266 in Healthy SubjectsStatus unknownNCT05172622Phase 1
• To Evaluate the Efficacy and Safety of JT-001 add-on in Paatients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin and DapagliflozinStatus unknownNCT05101135Phase 3
• To Evaluate the Efficacy and Safety of JLP-2002 on Symptoms of Overactive BladderCompletedNCT04917315Phase 3
• The Safety and PK Characteristics of the Co-administration of JLP-2002 and Comparator in Healthy VolunteersCompletedNCT04914221Phase 1
• A Study of Lubiprostone to Treat ConstipationStatus unknownNCT04861233
• A Study of NOV140201 (JPI-547) in Subject With Advanced Solid TumorsCompletedNCT04335604Phase 1
• Clinical Trial to Evaluate the Safety and Efficacy of JP-1366 in Patients With Erosive Gastroesophageal Reflux DiseaseCompletedNCT04282954Phase 2
• The PK Characteristics of the Co-administration of Rosuvastatin and Telmisartan/Amlodipine and JLP-1401 in Healthy Adult Volunteers VolunteersCompletedNCT03707899Phase 1
• The PK Characteristics of the Co-administration of Metformin SR and Rosuvastatin and JLP-1310 in Healthy Male Volunteers.CompletedNCT03690778Phase 1
• Pilot Clinical Trial to Evaluate the UNI-DEB for Unresectable Hepatocellular CarcinomaCompletedNCT03564405Not applicable
• Clinical Trial to Evaluate the Efficacy and Safety of UNI-DEB for Unresectable Hepatocellular CarcinomaCompletedNCT03533920Not applicable
• Drug-drug Interaction Following Oral Administration of Telmisartan/Amlodipine and Atorvastatin in Healthy Adult VolunteersCompletedNCT03461081Phase 1
• Clinical Trial to Investigate the Safety, Tolerability and Pharmacokinetics and Pharmacodynamics of JP-1366 Oral Administration in Healthy Male SubjectsCompletedNCT03383042Phase 1
• Compare the Pharmacokinetic Characteristics and the Safety Between Zeropix and Champix in Healthy Adult Male Subjects.CompletedNCT03362008Phase 1
• The PK Characteristics of the Co-administration of Rosuvastatin and Telmisartan/Amlodipine and JLP-1401 in Healthy Male Volunteers VolunteersCompletedNCT03247140Phase 1
• Study to Evaluate the Efficacy and Safety of Telmisartan/Amlodipine/RosuvastatinCompletedNCT03088254Phase 3
• Clinical Trial to Evaluate the Efficacy and Safety of JPI-289 in Patients With Acute Ischemic StrokeStatus unknownNCT03062397Phase 2
• The PK Characteristics of the Co-administration of Metformin SR and Rosuvastatin and JLP-1310 in Healthy Male VolunteersCompletedNCT02982798Phase 1
• Clinical Trial to Compare the Solifenacin/Tamsulosin Combination Therapy With Tamsulosin Monotherapy for LUTS Due to BPHCompletedNCT02972268Phase 3
• Metformin/Rosuvastatin Combination Therapy With in Patients With Type 2 Diabetes and DyslipidemiaCompletedNCT02827903Phase 3
• The PK Study of the JLP-1207 and Solifenacin/Tamsulosin in Healthy Male Volunteers.CompletedNCT02494349Phase 1
• Investigate the Effect of Food on the Pharmacokinetics of JLP-1310 in Healthy Male VolunteersCompletedNCT02449187Phase 1
• Investigate the Effect of Food on the Pharmacokinetic of JLP-1207 in Healthy Male VolunteersCompletedNCT02447367Phase 1
• Trial to Assess the Efficacy of Combination Formula of Aspirin Plus Clopidogrel in Patients With Coronary StentCompletedNCT02410083Phase 4
• The Evaluation of Safety, Tolerability and Pharmacokinetics/Pharmacodynamics of JPI-289 in Healthy Male VolunteersCompletedNCT02396069Phase 1
• The Pharmacokinetic Drug Interaction Between Rosuvastatin and Telmisartan/AmlodipineCompletedNCT02387619Phase 1
• Clinical Trial to Investigate the Pharmacokinetics Drug Interaction Between Metformin and RosuvastatinCompletedNCT02186483Phase 1
• Clinical Trial to Investigate the Pharmacokinetic Drug Interaction Between Solifenacin and TamsulosinCompletedNCT02180997Phase 1
• The Evaluation of Safety, Tolerability and Pharmacokinetics of Stroke Targeting Drug in Healthy VolunteersCompletedNCT01983358Phase 1
• Clinical Trial to Evaluate the Efficacy and the Safety of Antihypertensive TabletsCompletedNCT00553865Phase 2

← Jeil Pharmaceutical Co., Ltd. overview and focus areas